Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Income Statement [Abstract]
Commercialization revenue	$ 17,575	$ 28,640	$ 115,724	$ 55,997
Costs and operating expenses:
Cost of commercialization revenue	554	4,627	20,993	6,612
Research and development expenses	7,310	33,332	34,743	78,838
General and administrative expenses	6,514	8,912	17,989	20,025
Total costs and operating expenses	14,378	46,871	73,725	105,475
Income (loss) from operations	3,197	(18,231)	41,999	(49,478)
Other income (expense), net:
Interest income	143	450	379	1,054
Interest expense	(972)	(1,262)	(1,989)	(2,415)
Other income (expense), net	22	(6)	11	62
Total other income (expense), net	(807)	(818)	(1,599)	(1,299)
Income (loss) before provision for (benefit from) income taxes	2,390	(19,049)	40,400	(50,777)
Provision for (benefit from) income taxes	3	0	3	24
Net income (loss)	2,387	(19,049)	40,397	(50,801)
Other comprehensive gain (loss):
Unrealized gain (loss) on available-for-sale securities	0	41	(8)	190
Comprehensive income (loss)	$ 2,387	$ (19,008)	$ 40,389	$ (50,611)
Basic earnings (loss) per common share	$ 0.2	$ (3.1)	$ 3.52	$ (8.64)
Diluted earnings (loss) per common share	$ 0.19	$ (3.1)	$ 3.49	$ (8.64)
Basic weighted-average shares outstanding	12,197	6,143	11,484	5,883
Diluted weighted-average shares outstanding	12,310	6,143	11,576	5,883